Harris, M., Wang, Y., NW, P. , Jr, Hensley, K., Butterfield, D., & Carney, J. (1996). Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures. Journal of Neurochemistry, 67(1), 277-86. https://doi.org/10.1046/j.1471-4159.1996.67010277.x

Hensley, K., Butterfield, D., Hall, N., Cole, P., Subramaniam, R., Mark, R., … Aksenov, M. (1996). Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer’s disease-associated amyloid beta peptide. Annals of the New York Academy of Sciences, 786, 120-34. https://doi.org/10.1111/j.1749-6632.1996.tb39057.x (Original work published 1996)

Harris, M., Carney, J., Cole, P., Hensley, K., Howard, B., Martin, L., … Butterfield, D. (1995). beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer’s disease. Neuroreport, 6(14), 1875-9. https://doi.org/10.1097/00001756-199510020-00013 (Original work published 1995)

Aksenov, M., Aksenova, M., Harris, M., Hensley, K., Butterfield, D., & Carney, J. (1995). Enhancement of beta-amyloid peptide A beta(1-40)-mediated neurotoxicity by glutamine synthetase. Journal of Neurochemistry, 65(4), 1899-902. https://doi.org/10.1046/j.1471-4159.1995.65041899.x

Harris, M., Hensley, K., Butterfield, D., Leedle, R., & Carney, J. (1995). Direct evidence of oxidative injury produced by the Alzheimer’s beta-amyloid peptide (1-40) in cultured hippocampal neurons. Experimental Neurology, 131(2), 193-202. https://doi.org/10.1016/0014-4886(95)90041-1